Understanding the Preferences of Patients and Caregivers for Relapsed/Refractory Multiple Myeloma Treatment: A Mixed-Mode Patient-Centric Approach von Auclair, Daniel, Mansfield, Carol, Chari, Ajai, Cole, Craig E., Fiala, Mark A., Kaufman, Jonathan L., Orloff, Gregory, Siegel, David, Zonder, Jeff A., Mange, Brennan, Yesil, Jennifer, Dalal, Mehul, Mikhael, Joseph

Volltext

Perifosine Plus Bortezomib and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma Previously Treated With Bortezomib: Results of a Multicenter Phase I/II Trial von RICHARDSON, Paul G, WOLF, Jeff, MARTIN, Tom, SCHLOSSMAN, Robert, GHOBRIAL, Irene M, MUNSHI, Nikhil, LAUBACH, Jacob, ALLERTON, Jeff, HIDESHIMA, Teru, COLSON, Kathleen, PORADOSU, Enrique, GARDNER, Lesa, JAKUBOWIAK, Andrzej, SPORTELLI, Peter, ANDERSON, Kenneth C, ZONDER, Jeff, LONIAL, Sagar, IRWIN, David, DENSMORE, John, KRISHNAN, Amrita, RAJE, Noopur, BAR, Michael

Volltext

Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase 1b Study von Seymour, Erlene K., Li, Yiwei, Aboukameel, Amro, Ramchandren, Radhakrishnan, Sterbis, Golbon, Yang, Jay, Bhutani, Divaya, Mohammad, Ramzi, Azmi, Asfar Sohail, Zonder, Jeff

Volltext

Real-World Treatment Patterns in Patients with Light Chain (AL) Amyloidosis: Analysis of the Optum US Electronic Health Records and Commercial Claims Database von Dispenzieri, Angela, Zonder, Jeff, Hoffman, James, Wong, Sandy W., Liedtke, Michaela, Abonour, Rafat, D'Souza, Anita, Lee, Charlene, Nair, Sandhya, Potluri, Ravi, Weiss, Brendan M., Vermeulen, Jessica, Lam, Annette, Mehra, Maneesha

Volltext

Investigational CD47-Blocker TTI-622 Shows Single-Agent Activity in Patients with Advanced Relapsed or Refractory Lymphoma: Update from the Ongoing First-in-Human Dose Escalation S... von Patel, Krish, Ramchandren, Radhakrishnan, Maris, Michael, Lesokhin, Alexander M., von Keudell, Gottfried R., Cheson, Bruce D., Zonder, Jeff, Seymour, Erlene K., Catalano, Tina, Lin, Gloria H.Y., Uger, Bob, Petrova, Penka S., Roberge, Kathleen, Shou, Yaping, Iyer, Swami P.

Volltext

Daratumumab (DARA) Plus Carfilzomib, Pomalidomide, Dexamethasone (KPd) in Lenalidomide Refractory Multiple Myeloma (MM): A Multi-Center MMRC Study von Jasielec, Jagoda, Zonder, Jeff, Derman, Benjamin A, Reece, Donna E., Cole, Craig E., Berdeja, Jesus G., Wolfe, Brittany, Major, Sarah, Tinari, Kathryn M., Stefka, Andrew, Fazzi, Fabrizio, Whelan, Megan, Gleason, Christine, McIver, Amanda, Andreatos, Evangelia, Libao, Bernadette M., Juergens, Daniel, Griffith, Kent, Jakubowiak, Andrzej

Volltext

Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes von Mohamed, Anwar N., Bentley, Gail, Bonnett, Michelle L., Zonder, Jeff, Al‐Katib, Ayad

Volltext

S0204: Melphalan (MEL)-Based Tandem Autotransplants (TAT) for Multiple Myeloma (MM) with Thalidomide/Dexamethasone (TD) Induction and Thalidomide/Prednisone (TP) Maintenance: A Pha... von Hussein, Mohamad A., Jakubowiak, Andrzej J., Bolejack, Vanessa, Zonder, Jeff, Crowley, John, Barlogie, Bart

Volltext